Biocryst Pharmaceuticals (BCRX) Earnings (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Biocryst Pharmaceuticals (BCRX) earnings is -$458M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Biocryst Pharmaceuticals (BCRX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +756.66% |
| 3 Years TTM | +26.50% |
| 5 Years TTM | +16.93% |
| 10 Years TTM | +24.62% |
| All Time TTM | +17.94% |
Annual Earnings change of Biocryst Pharmaceuticals (BCRX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$722M | -373.56% |
| 2025 | $264M | -396.87% |
| 2024 | -$89M | -60.77% |
| 2023 | -$227M | -8.33% |
| 2022 | -$247M | +34.26% |
| 2021 | -$184M | +0.68% |
| 2020 | -$183M | +67.87% |
| 2019 | -$109M | +7.56% |
| 2018 | -$101M | +53.92% |
| 2017 | -$66M | +19.30% |
| 2016 | -$55M | +28.17% |
| 2015 | -$43M | -4.80% |
| 2014 | -$45M | +50.08% |
| 2013 | -$30M | -22.95% |
| 2012 | -$39M | -31.38% |
| 2011 | -$57M | +68.24% |
| 2010 | -$34M | +151.67% |
| 2009 | -$13M | N/A |
Comparison Biocryst Pharmaceuticals (BCRX) five years earnings CAGR with competitors
Biocryst Pharmaceuticals (BCRX) five years earnings CAGR is 16.93%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +488.78% |
| INCR | INC Research Holdings Inc | 64.08% | +278.48% |
| TLRY | Tilray Brands Inc | 57.78% | +241.22% |
| PRGO | Perrigo Company plc | 51.08% | +201.69% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +104.13% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +67.62% |
| UTHR | United Therapeutics Corp | 26.00% | +53.55% |
| SBFM | Sunshine Biopharma Inc | 23.97% | +41.55% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +27.92% |
| AYTU | Aytu BioPharma Inc | 21.24% | +25.47% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | +2.10% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -30.15% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -36.75% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -38.36% |
| ZTS | Zoetis Inc - Class A | 8.54% | -49.58% |
| KMDA | Kamada Ltd | 6.87% | -59.42% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -70.31% |
| PRFX | PRF Technologies Ltd | 4.38% | -74.13% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -77.85% |
| CPHI | China Pharma Holdings Inc | 3.58% | -78.85% |
| BHC | Bausch Health Companies Inc | 3.48% | -79.44% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -82.67% |